MLSSNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

MILESTONE SCIENTIFIC INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.33+0.01 (+1.99%)

Close on Oct 19, 2026

Market cap: $31.01M
P/E (TTM): –
Dividend yield: –

MILESTONE SCIENTIFIC INC. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Depreciation & Amortization	0.08	0.04	0.06	0.06	0.07	0.10	0.10	0.88	0.57	–	–	–	–	–	–	–
Stock-Based Compensation	0.95	1.35	1.47	1.50	0.79	0.55	0.18	0.41	0.65	1.85	–	–	–	–	–	–
Change in Accounts Receivable	-0.22	-0.16	0.36	0	0.14	0.63	0.27	-0.44	-0.73	0.64	-0.21	-0.01	-0.13	0.53	-0.17	-0.73
Change in Inventory	-0.07	-1.08	-1.10	-0.83	0.88	-0.80	0.30	0.91	1.00	-0.51	-0.88	-1.18	-0.68	0.15	0.20	-0.18
Change in Accounts Payable	0.41	0.33	-0.41	0.32	0.30	-0.90	0.32	0.23	-0.36	0.49	0.17	-0.52	-0.32	-1.59	0.61	2.17
Change in Unearned Revenue	–	–	–	–	–	–	-0.10	0.19	0.72	1.00	–	–	–	–	–	–
Operating Cash Flow	-2.92	-2.92	-5.33	-6.03	-4.03	-6.98	-1.78	-1.63	-1.23	-5.40	-2.95	0.38	1.26	-0.05	-0.57	-0.29
Capital Expenditures	-0.02	-0.01	–	-0.01	-0.02	-0.02	-0.01	-0.01	-0.01	-0.02	-0.07	-0.08	-0.01	0.00	-0.01	-0.03
Sale of Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00
Purchase of Investments	–	0	-7.93	0	–	–	–	–	–	–	–	-0.86	-0.48	–	–	–
Sale & Maturity of Investments	–	2.98	4.97	0	–	–	–	–	–	–	–	–	–	–	–	–
Investing Cash Flow	-0.02	2.97	-2.97	-0.01	-0.02	-0.02	-0.01	-0.02	-0.20	0.01	-3.73	-1.30	-0.56	-0.03	-0.04	-0.11
Stock Issued	–	–	2.57	0	0	18	1.97	–	0.15	2.57	–	–	0.20	0.15	0.03	–
Debt Issued	0.80	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Financing Cash Flow	0.79	0.23	2.56	-0.01	4.59	20	2.56	-0.25	0.46	4.80	0.50	10	0.28	0.15	0.08	–
Net Change in Cash	-2.15	0.28	-5.74	-6.05	0.54	13	0.77	-1.89	-0.97	-0.59	–	9.22	0.98	0.07	-0.53	-0.40
Free Cash Flow	-2.93	-2.93	–	-6.04	-4.05	-7.01	-1.79	-1.64	-1.24	-5.41	-3.01	0.29	1.25	-0.05	-0.58	-0.32
Interest Paid	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.02	0.09

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 70.2%
Operating margin: -43.6%
Net margin: -44.0%
Return on equity, FY2025: -132.4%

Financial strength

Current ratio: 1.85
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 47.0%

Valuation

P/E ratio: –
Price to sales: 3.29
Price to book: 8.93
Dividend yield: –